Synex Korea Healthcare Business Issue Report - DTx (Digital Therapeutics) 2023

As defined by the FDA, Digital Therapeutics (DTx) is a "Software as a Medical Device (SaMD) that provides evidence-based therapeutic interventions to non-patients for the purpose of preventing, managing, or treating a medical disorder or disease based on biometric information collected from general-purpose digital devices such as smartphones, tablet PCs, and wearable medical devices."
Currently, the domestic Digital Therapeutics industry is in its infancy. As of June 2023, only *** products have been recently approved, but they have not yet been used in earnest because the payment system has not yet been established by health insurance. Therefore, there is no market to estimate the size.
Currently, companies developing digital therapeutic devices are mostly ICT-based startups rather than traditional medical device developers. They are known to receive equity investment from large domestic pharmaceutical companies to develop their technologies, or to contract with pharmaceutical companies in advance for distribution rights at the pre-commercialization stage.
As of 19 May 2023, there are a total of *** digital therapeutic device products designated as innovative medical devices in Korea, and for each product, we examined the product development and launch trends to date.
In Korea, Aimmed's Somzz was the first to be approved on 2023-02-15, followed by Welt Corporation's Pillow Rx on April 19 of the same year as the second Digital Therapeutics.

Terms and Definitions
Disclaimer
Preface

1 Understanding Digital Therapeutics
1.1 Definition of DTx
1.2 Characteristics of Digital Therapeutics
1.3 Development History of Digital Therapeutics
1.4 Applications of Digital Therapeutics
1.5 Global Digital Therapeutics Market

2 DTx Market in Korea
2.1 Breakthrough Device Designation
2.2 Product Approval of MFDS
2.3 NHIS Listing and Coverage
2.3.1 Breakthrough Technology Designation
2.4 Clinical Trial Approval of MFDS
2.5 Current R&D in Korea

3 Major Suppliers of DTx in Korea
3.1 NUNAPS
3.2 DoBrain
3.3 LifeSemantics
3.4 S-Alpha Therapeutics
3.5 AIMMED
3.6 WELT
3.7 Other Suppliers
3.7.1 Neudive
3.7.2 Medimind (formerly known as F&I Korea)
3.7.3 Emocog
3.7.4 HAII
3.7.5 Huraypositive

4 Business Issues in DTx Market
4.1 Scope of DTx Classified as Medical Devices
4.2 Scope of Reimbursement DTx
4.3 Market Access Model of DTx in Korea
4.3.1 Target Conditions and Intended Uses
4.3.2 Clinical Grounds
4.3.3 Outlook for NHIS Coverage
4.3.4 Business Model Forecast

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved